- Home
- SCYX vs RAYA Comparison
SCYX vs RAYA Comparison
Compare SCYX & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- RAYA
- Stock Information
- Founded
- SCYX 1999
- RAYA 2019
- Country
- SCYX United States
- RAYA China
- Employees
- SCYX N/A
- RAYA N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- RAYA Metal Fabrications
- Sector
- SCYX Health Care
- RAYA Consumer Discretionary
- Exchange
- SCYX Nasdaq
- RAYA Nasdaq
- Market Cap
- SCYX 40.9M
- RAYA 34.2M
- IPO Year
- SCYX 2014
- RAYA 2022
- Fundamental
- Price
- SCYX $1.03
- RAYA $1.25
- Analyst Decision
- SCYX Buy
- RAYA
- Analyst Count
- SCYX 1
- RAYA 0
- Target Price
- SCYX N/A
- RAYA N/A
- AVG Volume (30 Days)
- SCYX 135.5K
- RAYA 4.3K
- Earning Date
- SCYX 03-12-2025
- RAYA 01-01-0001
- Dividend Yield
- SCYX N/A
- RAYA N/A
- EPS Growth
- SCYX N/A
- RAYA N/A
- EPS
- SCYX N/A
- RAYA N/A
- Revenue
- SCYX $3,746,000.00
- RAYA $22,816,585.00
- Revenue This Year
- SCYX $1,541.00
- RAYA $64.53
- Revenue Next Year
- SCYX $111.43
- RAYA $9.61
- P/E Ratio
- SCYX N/A
- RAYA N/A
- Revenue Growth
- SCYX N/A
- RAYA N/A
- 52 Week Low
- SCYX $0.82
- RAYA $0.55
- 52 Week High
- SCYX $3.07
- RAYA $1.78
- Technical
- Relative Strength Index (RSI)
- SCYX 50.55
- RAYA 51.03
- Support Level
- SCYX $1.00
- RAYA $1.20
- Resistance Level
- SCYX $1.06
- RAYA $1.30
- Average True Range (ATR)
- SCYX 0.07
- RAYA 0.05
- MACD
- SCYX 0.02
- RAYA 0.00
- Stochastic Oscillator
- SCYX 63.30
- RAYA 45.45
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.